MEMBER'S LOGINX
| Login Failure | ||||||||
|
||||||||
| Sign Up | Forgot Password? | ||||||||
- Home
- Research It
- Compare Company
- International - pharmaceuticals
- ALKEM LABORATORIES - TEVA PHARMA (Israel)
ALKEM LABORATORIES vs TEVA PHARMA (Israel) - Comparison Results
TEVA PHARMA (Israel)
Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
Financials
 ALKEM LABORATORIES  TEVA PHARMA |
| EQUITY SHARE DATA | |||||
|---|---|---|---|---|---|
| ALKEM LABORATORIES Mar-16 |
TEVA PHARMA Dec-13 |
ALKEM LABORATORIES/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
| High | Rs | 1,589 | 3,001 | - | |
| Low | Rs | 1,232 | 2,607 | - | |
| Sales per share (Unadj.) | Rs | 417.5 | 1,722.1 | - | |
| Earnings per share (Unadj.) | Rs | 56.3 | 107.6 | - | |
| Cash flow per share (Unadj.) | Rs | 64.7 | 246.8 | - | |
| Dividends per share (Unadj.) | Rs | 12.70 | 94.18 | - | |
| Dividend yield (eoy) | % | 0.9 | 3.4 | 26.8% | |
| Book value per share (Unadj.) | Rs | 292.9 | 1,913.0 | - | |
| Shares outstanding (eoy) | m | 119.57 | 848.00 | - | |
| Bonus/Rights/Conversions | - | - | - | ||
| Price / Sales ratio | x | 3.4 | 1.6 | 207.5% | |
| Avg P/E ratio | x | 25.1 | 26.1 | 96.1% | |
| P/CF ratio (eoy) | x | 21.8 | 11.4 | 191.9% | |
| Price / Book Value ratio | x | 4.8 | 1.5 | 328.5% | |
| Dividend payout | % | 22.6 | 87.5 | 25.8% | |
| Avg Mkt Cap | Rs m | 168,653 | 2,377,546 | 7.1% | |
| No. of employees | `000 | NA | 44.9 | 0.0% | |
| Total wages/salary | Rs m | 9,171 | 0 | - | |
| Avg. sales/employee | Rs Th | NM | 32,492.5 | - | |
| Avg. wages/employee | Rs Th | NM | 0 | - | |
| Avg. net profit/employee | Rs Th | NM | 2,029.8 | - | |
| INCOME DATA | |||||
|---|---|---|---|---|---|
| Net Sales | Rs m | 49,915 | 1,460,373 | 3.4% | |
| Other income | Rs m | 1,645 | 0 | - | |
| Total revenues | Rs m | 51,561 | 1,460,373 | 3.5% | |
| Gross profit | Rs m | 8,482 | 399,924 | 2.1% | |
| Depreciation | Rs m | 1,006 | 118,043 | 0.9% | |
| Interest | Rs m | 671 | 28,684 | 2.3% | |
| Profit before tax | Rs m | 8,451 | 253,197 | 3.3% | |
| Minority Interest | Rs m | -114 | 1,150 | -9.9% | |
| Prior Period Items | Rs m | 0 | 0 | - | |
| Extraordinary Inc (Exp) | Rs m | 0 | -166,210 | 0.0% | |
| Tax | Rs m | 1,606 | -3,091 | -52.0% | |
| Profit after tax | Rs m | 6,731 | 91,228 | 7.4% | |
| Gross profit margin | % | 17.0 | 27.4 | 62.1% | |
| Effective tax rate | % | 19.0 | -1.2 | -1,556.5% | |
| Net profit margin | % | 13.5 | 6.2 | 215.9% | |
| BALANCE SHEET DATA | |||||
|---|---|---|---|---|---|
| Current assets | Rs m | 27,062 | 986,331 | 2.7% | |
| Current liabilities | Rs m | 15,324 | 860,164 | 1.8% | |
| Net working cap to sales | % | 23.5 | 8.6 | 272.2% | |
| Current ratio | x | 1.8 | 1.1 | 154.0% | |
| Inventory Days | Days | 67 | 91 | 73.2% | |
| Debtors Days | Days | 41 | 96 | 43.0% | |
| Net fixed assets | Rs m | 12,610 | 476,990 | 2.6% | |
| Share capital | Rs m | 239 | 3,595 | 6.7% | |
| Net worth | Rs m | 35,027 | 1,622,198 | 2.2% | |
| Long term debt | Rs m | 1,212 | 746,721 | 0.2% | |
| Total assets | Rs m | 54,387 | 3,337,421 | 1.6% | |
| Interest coverage | x | 13.6 | 9.8 | 138.4% | |
| Debt to equity ratio | x | 0 | 0.5 | 7.5% | |
| Sales to assets ratio | x | 0.9 | 0.4 | 209.7% | |
| Return on assets | % | 13.6 | 3.6 | 378.8% | |
| Return on equity | % | 19.2 | 5.6 | 341.7% | |
| Return on capital | % | 24.9 | 4.9 | 504.1% | |
| CASH FLOW | |||||
|---|---|---|---|---|---|
| From Operations | Rs m | 7,259 | 232,708 | 3.1% | |
| From Investments | Rs m | 1,864 | -82,458 | -2.3% | |
| From Financial Activity | Rs m | -9,273 | -279,149 | 3.3% | |
| Net Cashflow | Rs m | -150 | -128,899 | 0.1% | |
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 71.89 Rs / USD
Compare ALKEM LABORATORIES With: ADCOCK INGRAM (S. Africa) MYLAN (US) ACTAVIS (US)
Compare ALKEM LABORATORIES With: DR. REDDYS LAB NOVARTIS IPCA LABS SHASUN PHARMA VENUS REMEDIES
Today's Market
Sensex Ends 82 Points Lower; Energy and Healthcare Stocks Witness Selling(Closing)
Indian share markets witnessed volatile trading activity throughout the day and ended marginally lower.
Related Views On News
Most Popular
The Next Few Days Are Crucial for Smallcap Investors - And 3 Must-Buy Stocks (Profit Hunter)
Feb 19, 2020While I have been writing about the rebound in smallcaps for quite some time now... I have shied from the question - When exactly is the smallcap rebound happening. Well, the answer is now.
Here's Why I Recommended 15 Stocks in One Day Flat 
(Views On News)
Feb 14, 2020
This proven strategy can give big returns in quick time.
The Top 8 Trading Mistakes You Should Avoid (Fast Profits Daily)
Feb 18, 2020Avoid these mistakes and your trading will turn much more profitable.
Corona Virus Could Trigger a Rally in this Stock (Profit Hunter)
Feb 20, 2020A company which benefits from crude oil and coronavirus - if you would like to know more about it read this.
These Rebirth of India Stocks Are Raring to Compete with Tesla (The 5 Minute Wrapup)
Feb 17, 2020There are Indian stocks which can soar like Tesla in the long-run.
More